Shejil Kumar Mariah Melek Peter Rohl
10.3389/fendo.2022.906012
Front Endocrinol (Lausanne)
2022 May 24;13:906012.
diabetes hypoglycemia insulinoma lutate lutetium neuroendocrine tumor type 2 diabetes
CC BY
https://pubmed.ncbi.nlm.nih.gov/35685218/
Diabetes Mellitus, Type 2 / complications Diabetes Mellitus, Type 2 / drug therapy Hypoglycemia / etiology Insulinoma / complications Insulins Neuroendocrine Tumors / pathology Pancreatic Neoplasms / pathology
Diabetes Mellitus, Type 2 / complications Diabetes Mellitus, Type 2 / drug therapy Hypoglycemia / etiology Insulinoma / complications Insulins Neuroendocrine Tumors / pathology Pancreatic Neoplasms / pathology Case Reports Review Aged, 80 and over Gallium Radioisotopes Humans Lutetium Male Positron Emission Tomography Computed Tomography Positron-Emission Tomography Radionuclide Imaging Radiopharmaceuticals / therapeutic use Gallium Radioisotopes Insulins Radiopharmaceuticals copper dotatate CU-64 Lutetium
PMC9171402
35685218
Case Report: Hypoglycemia Due to Metastatic Insulinoma in Insulin-Dependent Type 2 Diabetes Successfully Treated With 177 Lu-DOTATATE
2022